Navigation Links
MetLife Foundation Begins New Phase of Award-Winning Parenting Skills Campaign in Collaboration with the Partnership for a Drug-Free America(R)
Date:9/24/2007

NEW YORK, Sept. 24 /PRNewswire-USNewswire/ -- MetLife Foundation will begin the next phase of its award-winning parenting skills campaign, airing education messages created in cooperation with the nonprofit Partnership for a Drug-Free America(R) on radio stations in 11 markets nationwide through November. The radio campaign is backed by web resources and a free brochure for parents.

The campaign features radio messages, in both English and Spanish, which stress to parents the importance of talking with kids about drugs and alcohol, and staying involved in their children's lives in order to keep them healthy and drug free. Disturbingly, at a time when teens are faced with new threats such as the intentional abuse of prescription (Rx) painkillers and over-the- counter (OTC) cough medicines, the number of frequent discussions between parents and teens about the risks of drug abuse has decreased significantly.

The 2006 Partnership Attitude Tracking Study (PATS) on parents released just last month, confirms a 12 percent decline from 2005 in the frequent discussions (four or more) between parents and their teens about the dangers of drug and alcohol abuse (55 percent in 2005 down to 49 percent in 2006). Even more concerning is that a mere 36 percent of parents reported having in- depth conversations about abuse of prescription medications and only 33 percent have thoroughly discussed abuse of OTC cough and cold medicines with their teens.

Other recent Partnership research studies show the abuse of prescription and over-the-counter medicines has become an entrenched behavior in American teen culture. Nearly one in five teens (19 percent) report abusing prescription medications to get high, and one in 10 (10 percent) report abusing cough medicine to get high. Abuse of Rx and OTC medications is on par or higher than the abuse of illegal drugs such as Ecstasy (8 percent), cocaine/crack (10 percent), methamphetamine (8 percent) and heroin (5 percent).<
'/>"/>

SOURCE The Partnership for a Drug-Free America
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
2. Kalam To Lay Foundation Of Vellore Research Center
3. Nippon Foundation To Help Leprosy Patients
4. Parents Launch SV40 Cancer Foundation In Memory of Son
5. Cancer Aid And Research Foundation: Offering Endless Hope To Cancer Patients
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. PM Launches Healthcare Foundation For India
8. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
9. Gates Foundation to donate USD 104 million to TB Alliance
10. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
11. Gates Foundation Adopts Fight against Encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...stained Energy Enhancing Supplement, BOCA RATON, ...sed,nutritional supplement manufacturer, introduce...., Glyc,n Go, is the first and only chewable form...t, and the effects that it has on the,energy syste...trainers,around the globe., In clinical trials, t...
(Date:10/13/2008)...wswire/ -- NeoVista, Inc., presented,yesterday the...l,brachytherapy device on choroidal neovascular le...tina Specialist,s (ASRS) 26th Annual Meeting. The,...S., of The Methodist,Hospital, Houston, Texas, dem...y and ocular coherence tomography (OCT) in many pa...
(Date:10/13/2008)...taJobs.com and numerous newspaper affiliates have ...com . AtlantaJobs.com is the newest online job bo...bseekers in the metro Atlanta area. , ...-- AtlantaJobs.com and numerous newspaper affili...aJobs.com is the newest online job board dedicate...
(Date:10/12/2008)... Five neonatology fellows have been awarded grants...e area of follow-up care of the premature infant a...ts, which underscore MedImmune,s commitment to exp...ovide each recipient,s institution a $35,000 grant...recipients were acknowledged on Sunday, October 12...
Breaking Medicine News(10 mins):Health News:NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting 2Health News:NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting 3Health News:Atlanta Area Job Board Launches New Local Job Board to Connect Local Employers and Jobseekers 2Health News:MedImmune grants 5 new fellowships to help expand premature infant follow-up care research 2
...ts. Now, BT Offices and Vans will sport an anti-sm...ng is banned in the BT premises as well as in the ...tantly, this move might encourage “anti-smoking” i...n. The anti-smoking activists have seconded this ...
... improvement with Viagra could now benefit from st...ighlight the use of statins for management of endo...m erectile dysfunction. The result of this small, ...ennsylvania researchers is published in the Journa...
... Railways to take off chicken and egg related dish...n issued to all the Zonal Railways and other railw...fficial quoted that such a decision was taken upon...rest. As the disease itself is highly contagious,...
...construct a world-class cancer hospital and resear...come up at Rajarhat,// at the cost of Rs. 1.2 bill... Centre (TMC) would come up on a 10-acre plot, Wes...tacharjee and Tata Group chairman Ratan Tata said,...
Other Medicine News:Health News:Statins For Erectile Dysfunction- An Alternative To Viagra? 2
(Date:10/12/2008)...and WASHINGTON, Oct. 12 /- ...announced results from an analysis,of nearly 7,500..., which,are designed to confirm the performance of...nary Stent System in real-world practice. The,two-...t reduced clinical,restenosis in patients with dia...
(Date:10/10/2008)...Mich., Oct. 10 /- Diplomat Specialty,...s selected Diplomat,Specialty Pharmacy to be one o..., national Therapy Optimization Study for Multiple...OP MS study, is to examine the benefits of a,speci...ance, adherence and,patient outcomes. Targeted pat...
(Date:10/10/2008)..., Oct. 10 /- Inverness Medi...vider of near-patient,diagnostics, monitoring and ...n Ki-moon, the Secretary-General of the United Nat...eventeen of the world,s leading,research-based and...Inverness, together with senior officials from the...
(Date:10/10/2008)...lif., Oct. 10 /- TriReme Medical Inc.... to affix the CE (Conformite,Europeenne) marking a...y,Stent System, a unique main vessel stent system ...urcations., Representing the next generation in b...tential use in a quarter of the 2.2 million,angiop...
Breaking Medicine Technology:TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Leading Childrens Hospital Utilizes MEDais Solutions to Deliver Outstanding Care 4025 1Leading Childrens Hospital Utilizes MEDais Solutions to Deliver Outstanding Care 4025 2Nventa updates progress of cervical dysplasia trial with new HspE7 1339 1Nventa updates progress of cervical dysplasia trial with new HspE7 1339 2Nventa updates progress of cervical dysplasia trial with new HspE7 1339 3Nventa updates progress of cervical dysplasia trial with new HspE7 1339 4Nventa updates progress of cervical dysplasia trial with new HspE7 1339 5Nile Therapeutics Appoints Pedro Granadillo to Board of Directors 1334 1Nile Therapeutics Appoints Pedro Granadillo to Board of Directors 1334 2Nile Therapeutics Appoints Pedro Granadillo to Board of Directors 1334 3FDA Panel Mulls Ban on Kids Cold Medicines 4019 1FDA Panel Mulls Ban on Kids Cold Medicines 4019 2FDA Panel Mulls Ban on Kids Cold Medicines 4019 3FDA Panel Mulls Ban on Kids Cold Medicines 4019 4
... Data presented at the 11th International Myeloma ... activity of perifosine in,combination with bortez...asone, in patients with relapsed/refractory multip... relapsed/refractory,Waldenstrom,s macroglobulinem... -- Keryx,Biopharmaceuticals, Inc. today announced...
... IRVING, Texas--(BUSINESS WIRE)--Jun 29, 2007 - Re...entation of new,preclinical data showing their lea...A 402, is effective at protecting against,common t... This,data was presented at the annual meeting of ...n Cancer (MASSC) in St Gallen,Switzerland., Reata...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 2RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 3
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: